| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |